|
Dr. Frudakis founded GAFF biologic, the predecessor in interest to DNAPrint, in 1998. He served as its President and Chief Executive Officer. Prior to founding GAFF biologic, Dr. Frudakis was a research scientist for Corixa Corporation for four years. While at Corixa he developed several new techniques for RNA fingerprinting, managed and executed high-throughput gene discovery programs for various cancers and was instrumental in the company's early success in attracting research and development partners. In all, his work has resulted in a patent portfolio for over 350 unique genes and two products. Dr. Frudakis is a Phi Beta Kappa, Magna cum laude graduate of the University of California Irvine where he received a BS degree in Biological Sciences. Dr. Frudakis also earned a doctorate degree in molecular and cell biology from the University of California Berkeley. | 